Table 3

Mean ED50 values and 95% CLs for the midazolam discrimination dose-effect curve alone and after pretreatment with various compounds

Drug/DoseMidazolam DiscriminationRate % Control ± S.E.M.
ED5095% CLBefore MidazolamAfter Midazolam
mg/kg
Control0.150.08–0.23102  ± 697  ± 4
+ Buspirone
 0.1 mg/kg0.130.03–0.3396  ± 1630  ± 15
 0.32 mg/kg0.090.01–0.22102  ± 1545  ± 36
 1.0 mg/kgN.S.N.S.36  ± 31N.S.
+ GHB
 100.0 mg/kg0.220.05–0.5187  ± 11108  ± 12
 320.0 mg/kg0.220.05–0.4991  ± 587  ± 27
 560.0 mg/kg0.033-a 0.01–0.07105  ± 971  ± 12
+ Ketamine
 1.0 mg/kg0.120.10–0.13109  ± 886  ± 25
 3.2 mg/kgN.S.N.S.0N.S.
+ Diphenhydramine
 3.2 mg/kg0.140.06–0.25145  ± 21134  ± 19
 10.0 mg/kg0.090.08–0.10132  ± 3137  ± 25
 17.8 mg/kg0.343-a 0.20–0.54129  ± 10108  ± 35
+ Valproic acid
 320.0 mg/kg0.120.03–0.29116  ± 11110  ± 26
 560.0 mg/kg0.053-a 0.02–0.0998  ± 1783  ± 35
 1000.0 mg/kg0.033-a 0.01–0.0896  ± 1184  ± 56

Rate of responding includes rate after administration of the pretreatment drug alone (before midazolam) and rate after administration of the pretreatment drug followed by the dose of midazolam resulting in a group average of ≥80% midazolam-lever responding (after midazolam). Data are from at least three monkeys.

  • N.S., not studied.

  • 3-a  Significantly different from control (p < 0.05).